Media and Tests Identification of to Simplify the Recognition And
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Characterization and Antibiotic Sensitivity Profile of Bacteria Isolated from Patients with Respiratory Tract Infections in Bangladesh
Characterization and Antibiotic Sensitivity Profile of Bacteria Isolated from Patients with Respiratory Tract Infections in Bangladesh Shukla Promite1, Sajal K. Saha2, Sunjukta Ahsan1 and Marufa Zerin Akhter1 1Department of Microbiology, University of Dhaka, Dhaka, Bangladesh 2Department of General Practice, Monash University, Building 1, 270 Ferntree Gully Road, Notting Hill VIC 3168, Australia (Received: October 08, 2017; Accepted: December 15, 2017; Published (web): December 23, 2017) ABSTRACT: The study was aimed to characterize bacterial isolates from respiratory tract infections (RTI) and investigate their antibiotic sensitivity profile. Selective media and biochemical tests were used to characterize 40 bacterial isolates. Antibiotic sensitivity testing was conducted using Kirby-Bauer disc diffusion method. About 42.5% (17) RTI patients were infected by Klebsiella pneumoniae, 30% (12) by Escherichia coli and 27.5% (11) by Pseudomonas aeruginosa with no significant gender variation (p-value <0.578). Overall, 47% (out of 20) antibiotics were sensitive, whereas 48% were resistant. Surprisingly, 18% P. aeruginosa and 20% K. pneumoniae were carbapenem-resistant and 4 out of 7 cephalosporin antibiotics were highly resistant irrespective of pathogens. E. coli showed better sensitivity to nitrofurantoin (78%) and levofloxacin (89%), while K. pneumoniae was insensitive to cotrimoxazole (88%), gentamycin (77%) and piperacillin/tazobactam (66%). On the other hand, P. aeruginosa did not respond to P. aeruginosa to nalidixic acid (60%) and ciprofloxacin (60%). This study concludes that nitrofurantoin, levofloxacin, cotrimoxazole, gentamycin and piperacillin/tazobactam antibiotics could be better alternative in treating bacterial RTIs. Key words: Antibiotic sensitivity, bacterial pathogens, RTIs, Bangladesh. INTRODUCTION Antibiotic resistance (AR) is a global public The rise of AR in Bangladesh is probably due to 1 health concern. -
MIO Medium (Motility Indole Ornithine Medium) M378
MIO Medium (Motility Indole Ornithine Medium) M378 Motility Indole Ornithine Medium (MIO Medium) is used for the identification of Enterobacteriaceae on the basis of motility, indole production and ornithine decarboxylase activity. Composition** Ingredients Gms / Litre Casein enzymic hydrolysate 10.000 Peptic digest of animal tissue 10.000 Yeast extract 3.000 L-Ornithine hydrochloride 5.000 Dextrose 1.000 Bromocresol purple 0.020 Agar 2.000 Final pH ( at 25°C) 6.5±0.2 **Formula adjusted, standardized to suit performance parameters Directions Suspend 31.02 grams in 1000 ml distilled water. Heat to boiling to dissolve the medium completely. Dispense in test tubes in 5 ml amounts. Sterilize by autoclaving at 15 lbs pressure (121°C) for 15 minutes. Cool the tubes in an upright position. Principle And Interpretation Motility, indole production and ornithine decarboxylation are routine biochemical tests employed during identification of Enterobacteriaceae . Motility can be demonstrated microscopically (hanging drop) or macroscopically (tube method), where motility is observed as a diffused zone of growth flaring out from the line of inoculation. Indole test is carried out to determine the ability of an organism to split indole from tryptophan by the tryptophanase enzyme. On reaction with Kovacs reagent, indole combines with the colour in the alcohol layer, which is visualized as a red ring (in the alcohol layer) (1). If the test organisms possess the specific decarboxylase enzyme, then ornithine is decarboxylated to putrescine, an amine, resulting in a subsequent rise in the pH of the medium towards alkalinity. This causes the pH indicator bromocresol purple to change from purple to yellow colour. -
Uncommon Pathogens Causing Hospital-Acquired Infections in Postoperative Cardiac Surgical Patients
Published online: 2020-03-06 THIEME Review Article 89 Uncommon Pathogens Causing Hospital-Acquired Infections in Postoperative Cardiac Surgical Patients Manoj Kumar Sahu1 Netto George2 Neha Rastogi2 Chalatti Bipin1 Sarvesh Pal Singh1 1Department of Cardiothoracic and Vascular Surgery, CN Centre, All Address for correspondence Manoj K Sahu, MD, DNB, Department India Institute of Medical Sciences, Ansari Nagar, New Delhi, India of Cardiothoracic and Vascular Surgery, CTVS office, 7th floor, CN 2Infectious Disease, Department of Medicine, All India Institute of Centre, All India Institute of Medical Sciences, New Delhi-110029, Medical Sciences, Ansari Nagar, New Delhi, India India (e-mail: [email protected]). J Card Crit Care 2020;3:89–96 Abstract Bacterial infections are common causes of sepsis in the intensive care units. However, usually a finite number of Gram-negative bacteria cause sepsis (mostly according to the hospital flora). Some organisms such as Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus are relatively common. Others such as Stenotrophomonas maltophilia, Chryseobacterium indologenes, Shewanella putrefaciens, Ralstonia pickettii, Providencia, Morganella species, Nocardia, Elizabethkingia, Proteus, and Burkholderia are rare but of immense importance to public health, in view of the high mortality rates these are associated with. Being aware of these organisms, as the cause of hospital-acquired infections, helps in the prevention, Keywords treatment, and control of sepsis in the high-risk cardiac surgical patients including in ► uncommon pathogens heart transplants. Therefore, a basic understanding of when to suspect these organ- ► hospital-acquired isms is important for clinical diagnosis and initiating therapeutic options. This review infection discusses some rarely appearing pathogens in our intensive care unit with respect to ► cardiac surgical the spectrum of infections, and various antibiotics that were effective in managing intensive care unit these bacteria. -
2021 ECCMID | 00656 in Vitro Activities of Ceftazidime-Avibactam and Comparator Agents Against Enterobacterales
IHMA In Vitro Activities of Ceftazidime-avibactam and Comparator Agents against Enterobacterales and 2122 Palmer Drive 00656 Schaumburg, IL 60173 USA Pseudomonas aeruginosa from Israel Collected Through the ATLAS Global Surveillance Program 2013-2019 www.ihma.com M. Hackel1, M. Wise1, G. Stone2, D. Sahm1 1IHMA, Inc., Schaumburg IL, USA, 2Pfizer Inc., Groton, CT USA Introduction Results Results Summary Avibactam (AVI) is a non-β- Table 1 Distribution of 2,956 Enterobacterales from Israel by species Table 2. In vitro activity of ceftazidime-avibactam and comparators agents Figure 2. Ceftazidime and ceftazidime-avibactam MIC distribution against 29 . Ceftazidime-avibactam exhibited a potent lactam, β-lactamase inhibitor against Enterobacterales and P. aeruginosa from Israel, 2013-2019 non-MBL carbapenem-nonsusceptible (CRE) Enterobacterales from Israel, antimicrobial activity higher than all Organism N % of Total mg/L that can restore the activity of Organism Group (N) %S 2013-2019 comparator agents against all Citrobacter amalonaticus 2 0.1% MIC90 MIC50 Range ceftazidime (CAZ) against Enterobacterales (2956) 20 Enterobacterales from Israel (MIC90, 0.5 Citrobacter braakii 5 0.2% Ceftazidime-avibactam 99.8 0.5 0.12 ≤0.015 - > 128 Ceftazidime Ceftazidime-avibactam organisms that possess Class 18 mg/L; 99.8% susceptible). Citrobacter freundii 96 3.2% Ceftazidime 70.1 64 0.25 ≤0.015 - > 128 A, C, and some Class D β- Cefepime 71.8 > 16 ≤0.12 ≤0.12 - > 16 16 . Susceptibility to ceftazidime-avibactam lactmase enzymes. This study Citrobacter gillenii 1 <0.1% Meropenem 98.8 0.12 ≤0.06 ≤0.06 - > 8 increased to 100% for the Enterobacterales Amikacin 95.4 8 2 ≤0.25 - > 32 14 examined the in vitro activity Citrobacter koseri 123 4.2% when MBL-positive isolates were removed Colistin (n=2544)* 82.2 > 8 0.5 ≤0.06 - > 8 12 of CAZ-AVI and comparators Citrobacter murliniae 1 <0.1% Piperacillin-tazobactam 80.4 32 2 ≤0.12 - > 64 from analysis. -
05686 DMACA (Indol Detection Disks)
05686 DMACA (Indol Detection Disks) The DMACA Indole discs are used for Indole test to determine the ability of an organism to split tryptophan into indole and α-aminopropionic acid. The presence of indole can be detected by the addition of DMACA which results in a bluish-purple complex. With this method it is possible to differentiate Escherichia coli from Klebsiella. Composition: (1 package contains 50 disks) The discs contain p-Dimethylaminocinnamaldehyde (DMACA). Directions: Place the disc on suspected colony from e.g. UTI ChromoSelect Agar, modified (16636) or Christensen’s Urea Agar (27048) plate on filter paper. Observe for appearance of blue-purple color within 10-30 seconds. Quality control: Test Organisms (ATCC) DMACA Escherichia coli (25922) + Pseudomonas aeruginosa (27853) - Klebsiella pneumoniae (13883) - 1. Staphylococcus aureus 2. Escherichia coli Page 1 of 2 References: 1. R. Vracko, J.C. Sherris, Indole-spot test in bacteriology., Am. J. Clin. Pathol., 39, 429 (1963) 2. V.L. Sutter, W.T. Carter, Evaluation of media and reagents for indole-spot test in anaerobic bacteriology., Am. J. Clin. Pathol., 58, 335 (1972) 3. G.D. Fay, A.L. Barry, Methods for detecting indole production by gram-negative nonsporeforming anaerobes., Appl. Micro. 27, 562 (1974) 4. D.F. Welch, P.A. Ahlin, J.M. Matsen, Differentiation of Haemophilus spp. in respiratory isolate cultures by an indole spot test., J. Clin. Micro. 15, 216 (1982) 5. H.D. Isenberg, Ed., Clinical microbiology procedures handbook, Vol 1., Washington, DC, ASM (1992) 6. B.A. Forbes, D.F. Sahm, A.S. Weissfeld, Bailey and Scott's diagnostic microbiology., 10th ed., St Louis, Mosby (1998) 7. -
경추 척수 손상 환자에서 발생한 Providencia Rettgeri 패혈증 1예 조현정·임승진·천승연·박권오·이상호·박종원·이진서·엄중식 한림대학교 의과대학 내과학교실
Case Report Infection & DOI: 10.3947/ic.2010.42.6.428 Chemotherapy Infect Chemother 2010;42(6):428-430 경추 척수 손상 환자에서 발생한 Providencia rettgeri 패혈증 1예 조현정·임승진·천승연·박권오·이상호·박종원·이진서·엄중식 한림대학교 의과대학 내과학교실 A Case of Providencia rettgeri Sepsis in a Patient with Hyun-Jung Cho, Seung-Jin Lim, Seung-Yeon Chun, Cervical Cord Injury Kwon-Oh Park, Sang-Ho Lee, Jong-Won Park, Jin- Seo Lee, and Joong-Sik Eom Providencia rettgeri is a member of Enterobacteriacea that is known to cause Department of Internal Medicine, Hallym Univer- urinary tract infection (UTI), septicemia, and wound infections, especially in sity College of Medi cine, Seoul, Korea immunocompromised patients and in those with indwelling urinary catheters. We experienced a case of UTI sepsis by Providencia rettgeri in a patient with spinal cord injury. The patient had only high fever without urinary symptoms or signs after high dose intravenous methylprednisolone. The laboratory results showed leukocytosis (21,900/μL, segmented neutrophils 91.1%) and pyuria. Cefepime was given empirically and it was switched to oral trimethoprim-sulfamethoxazole because P. rettgeri was identified from blood and urine culture which was susceptible to TMP-SMX. The patient was improved clinically but P. rettgeri was not eradicated microbiologically. To the best of our knowledge, this is the first case report on sepsis caused by Providencia rettgeri in Korea. Key Words: Providencia rettgeri, Sepsis, Urinary tract infection Introduction The genus Providencia is a member of the Enterobacteriaceae family which commonly dwells in soil, water, and sewage [1, 2]. Providencia rettgeri is one of five Providencia species that is known to cause various infections, especially the Copyright © 2010 by The Korean Society of Infectious Diseases | Korean urinary tract infection (UTI) [3]. -
The LOUISIANA ANTIBIOGRAM Louisiana Antibiotic Resistance 2014
The LOUISIANA ANTIBIOGRAM Louisiana Antibiotic Trends in Antibiotic Resistance Resistance 2014 in Louisiana 2008 Zahidul Islam MBBS, MPH, Raoult C Ratard MD MPH Contributors to this report: Lauren Kleamenakis MPH, Anup Subedee MD MPH and Raoult Ratard MD MPH. This report covers bacteria causing severe human infections and the antibiotics used to treat those infections. Resistance to other antimicrobials (antivirals, antifungals and anti-parasitic drugs) are not included for lack of systematic reporting and collection of comprehensive data. Contents 1-Introduction ............................................................................................................................................... 3 1.1-Bacterial resistance to antibiotics is a major threat to human health .................................................. 3 1.2-Tracking resistance patterns is a major action in the fight against antibiotic resistance ..................... 3 2-Methods ..................................................................................................................................................... 3 2.1-Active surveillance .............................................................................................................................. 3 2.2-Antibiogram collection ....................................................................................................................... 3 2.3-Analysis .............................................................................................................................................. -
Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea—A Systematic Review of the Literature
microorganisms Review Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea—A Systematic Review of the Literature Klaudia Tutka, Magdalena Zychowska˙ and Adam Reich * Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-055 Rzeszow, Poland; [email protected] (K.T.); [email protected] (M.Z.)˙ * Correspondence: [email protected]; Tel.: +48-605076722 Received: 30 August 2020; Accepted: 6 November 2020; Published: 8 November 2020 Abstract: Rosacea is a chronic inflammatory skin disorder of a not fully understood pathophysiology. Microbial factors, although not precisely characterized, are speculated to contribute to the development of the condition. The aim of the current review was to summarize the rosacea-associated alterations in the skin, blood, and gut microbiome, investigated using culture-independent, metagenomic techniques. A systematic review of the PubMed, Web of Science, and Scopus databases was performed, according to PRISMA (preferred reporting items for systematic review and meta-analyses) guidelines. Nine out of 185 papers were eligible for analysis. Skin microbiome was investigated in six studies, and in a total number of 115 rosacea patients. Blood microbiome was the subject of one piece of research, conducted in 10 patients with rosacea, and gut microbiome was studied in two papers, and in a total of 23 rosacea subjects. Although all of the studies showed significant alterations in the composition of the skin, blood, or gut microbiome in rosacea, the results were highly inconsistent, or even, in some cases, contradictory. Major limitations included the low number of participants, and different study populations (mainly Asians). Further studies are needed in order to reliably analyze the composition of microbiota in rosacea, and the potential application of microbiome modifications for the treatment of this dermatosis. -
Burkdiff: a Real-Time PCR Allelic Discrimination Assay for Burkholderia Pseudomallei and B
BurkDiff: A Real-Time PCR Allelic Discrimination Assay for Burkholderia Pseudomallei and B. mallei Jolene R. Bowers1*, David M. Engelthaler1, Jennifer L. Ginther2, Talima Pearson2, Sharon J. Peacock3, Apichai Tuanyok2, David M. Wagner2, Bart J. Currie4, Paul S. Keim1,2 1 Translational Genomics Research Institute, Flagstaff, Arizona, United States of America, 2 Northern Arizona University, Flagstaff, Arizona, United States of America, 3 Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 4 Menzies School of Health Research, Darwin, Australia Abstract A real-time PCR assay, BurkDiff, was designed to target a unique conserved region in the B. pseudomallei and B. mallei genomes containing a SNP that differentiates the two species. Sensitivity and specificity were assessed by screening BurkDiff across 469 isolates of B. pseudomallei, 49 isolates of B. mallei, and 390 isolates of clinically relevant non-target species. Concordance of results with traditional speciation methods and no cross-reactivity to non-target species show BurkDiff is a robust, highly validated assay for the detection and differentiation of B. pseudomallei and B. mallei. Citation: Bowers JR, Engelthaler DM, Ginther JL, Pearson T, Peacock SJ, et al. (2010) BurkDiff: A Real-Time PCR Allelic Discrimination Assay for Burkholderia Pseudomallei and B. mallei. PLoS ONE 5(11): e15413. doi:10.1371/journal.pone.0015413 Editor: Frank R. DeLeo, National Institutes of Health, United States of America Received July 26, 2010; Accepted September 12, 2010; Published November 12, 2010 Copyright: ß 2010 Bowers et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. -
Escherichia Coli Isolates Causing Asymptomatic Bacteriuria in Catheterized and Noncatheterized Individuals Possess Similar Virulence Propertiesᰔ 1 2 1 2
JOURNAL OF CLINICAL MICROBIOLOGY, July 2010, p. 2449–2458 Vol. 48, No. 7 0095-1137/10/$12.00 doi:10.1128/JCM.01611-09 Copyright © 2010, American Society for Microbiology. All Rights Reserved. Escherichia coli Isolates Causing Asymptomatic Bacteriuria in Catheterized and Noncatheterized Individuals Possess Similar Virulence Propertiesᰔ 1 2 1 2 Rebecca E. Watts, Viktoria Hancock, Cheryl-Lynn Y. Ong, Rebecca Munk Vejborg, Downloaded from Amanda N. Mabbett,1 Makrina Totsika,1 David F. Looke,3 Graeme R. Nimmo,4 Per Klemm,2 and Mark A. Schembri1* School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia1; Microbial Adhesion Group, DTU Food, Technical University of Denmark, Lyngby, Denmark2; and Infection Management Services, Princess Alexandra Hospital,3 and Queensland Health Pathology Service, Department of Microbiology, Royal Brisbane and Women’s Hospital,4 Brisbane, Queensland, Australia Received 19 August 2009/Returned for modification 12 November 2009/Accepted 22 April 2010 http://jcm.asm.org/ Urinary tract infections (UTIs) are among the most common infectious diseases of humans, with Escherichia coli being responsible for >80% of all cases. Asymptomatic bacteriuria (ABU) occurs when bacteria colonize the urinary tract without causing clinical symptoms and can affect both catheterized patients (catheter- associated ABU [CA-ABU]) and noncatheterized patients. Here, we compared the virulence properties of a collection of ABU and CA-ABU nosocomial E. coli isolates in terms of antibiotic resistance, phylogenetic grouping, specific UTI-associated virulence genes, hemagglutination characteristics, and biofilm formation. CA-ABU isolates were similar to ABU isolates with regard to the majority of these characteristics; exceptions were that CA-ABU isolates had a higher prevalence of the polysaccharide capsule marker genes kpsMT II and on October 22, 2015 by University of Queensland Library kpsMT K1, while more ABU strains were capable of mannose-resistant hemagglutination. -
Spot Indole Reagent
PRODUCT DETERIORATION This product should not be used if (1) the color has changed, (2) the expiration date has passed, or (3) there are other signs of deterioration. SPOT INDOLE REAGENT SPECIMEN COLLECTION, STORAGE, TRANSPORT Specimens should be collected and handled INTENDED USE 3 Remel Spot Indole Reagent is recommended for use following recommended guidelines. in qualitative procedures to determine the ability of an organism to split indole from the tryptophan MATERIALS REQUIRED BUT NOT SUPPLIED molecule. (1) Loop sterilization device, (2) Inoculating loop, swab, collection containers, (3) Incubators, alternative SUMMARY AND EXPLANATION environmental systems, (4) Supplemental media, Vracko and Sherris, in 1963, utilized Spot Indole (5) Quality control organisms, (6) Whatman (No. 1) Reagent for the presumptive separation of the filter paper. Proteus species and Escherichia coli.1 In 1969, Lowrance, Reich, and Traub found ρ-Dimethylamino- PROCEDURE cinnamaldehyde to be the most sensitive indole Filter Paper Method: reagent, capable of detecting 3 mcg of indole per 1. Dispense 1 or 2 drops of reagent onto a piece of milliliter of medium.2 Whatman (No. 1) filter paper or equivalent. 2. Smear the growth from an actively growing pure PRINCIPLE culture onto the saturated filter paper. Intracellular enzymes (i.e., tryptophanases) mediate 3. Observe for the development of a blue color the production of indole by hydrolytic activity against within 1 to 3 minutes. the amino acid tryptophan. Indole combines with Swab Method: dimethylaminocinnamaldehyde to form a blue-green 1. Dispense 1 or 2 drops of reagent onto the tip of compound. The reaction occurs by a condensation a cotton swab. -
New Drugs – Part Ii Jacqueline King, Pharm.D
7/7/2016 ANTIBIOTICS AND ANTIFUNGALS 2016 ANNUAL MEETING NEW DRUGS – PART II JACQUELINE KING, PHARM.D. TARA MCNULTY, CPHT, RPHT PHARMACY OPERATIONS SUPERVISOR PROJECT MANAGER UFHEALTH CANCER CENTER WELLCARE HEALTH PLANS, INC [email protected] [email protected] http://s3.amazonaws.com/readers/2010/05/28/bacteria_1.jpg 2016 ANNUAL MEETING DISCLOSURE BACTERIA • Jacqueline King, Pharm.D. • I do not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity, or any affiliation with an organization whose philosophy could potentially bias my presentation • Tara, McNulty, CPhT, RPhT • I do not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity, or any affiliation with an organization whose philosophy could potentially bias my presentation http://www.dbriers.com/tutorials/wp- content/uploads/2012/12/GramPositiveNegative21.jpg https://microbewiki.kenyon.edu/images/1/1b/Gram.jpg 2016 ANNUAL MEETING 2016 ANNUAL MEETING OBJECTIVES ANTIBIOTIC RESISTANCE • Explore new medications for the treatment of infectious diseases, including HIV • Antibiotic resistance occurs when an antibiotic has lost and Hepatitis C its ability to control or kill bacterial growth • Analyze the impact of the new agents within clinical practice • Causes of antibiotic resistance: Drugs not appropriately prescribed, not completing courses of antibiotics, • Utilize